Companies / Alebund
Alebund
Yangzhou, China
Alebund is a biopharmaceutical company focused on developing innovative treatments for kidney diseases and related chronic diseases.
Alebund, based in Yangzhou, China, has 2 investors on file, among them Lilly Asia Ventures and SymBiosis Capital Management. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Lilly Asia Ventures
60 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (96%), Fintech (2%), Robotics & Hardware (2%).
See Lilly Asia Ventures' full profile · Who invests alongside it
More from SymBiosis Capital Management
28 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See SymBiosis Capital Management's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Alebund and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lilly Asia Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/alebund.com/investors
# also
GET /v1/companies/alebund.com
GET /v1/companies/alebund.com/news